Baby aspirin cuts fat buildup in liver disease patients, in small study

PatrickSison/APLow-doseaspirinledtoareductioninliverfatamongpatientswithmetabolic-associatedliverdis EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest




fashion

author:leisure time    Page View:7995
Thomas Massie -- health policy coverage from STAT
Rep. Thomas Massie (R-Ky.) Kevin Dietsch/Getty Images

WASHINGTON — House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious disease research to legislation that could ultimately fund federal health agencies like the National Institutes of Health.

The bill would bar any federal agencies from funding so-called gain-of-function research, which involves altering a pathogen to study its spread, potentially making it more transmissible or severe in the process.

advertisement

The spending bill already included a restriction on funding this research in any country determined to be a “foreign adversary,” including China. Scientists at the Wuhan Institute of Virology studied gain-of-function in some viruses, fueling theories that the Covid-19 pathogen was a lab leak. Those theories have never definitively been proven.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In